Elicio Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
19 Mar 24 | SellUS$537,524 | Clal Biotechnology Industries Ltd. | Company | 82,696 | US$6.50 |
Insider Trading Volume
Insider-Käufe: Die Daten reichen nicht aus, um festzustellen, ob Insider in den letzten 3 Monaten mehr Aktien gekauft als verkauft haben.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 2.045 | 0,02 % |
Public Companies | 199.564 | 1,95 % |
Institutions | 338.635 | 3,31 % |
VC/PE Firms | 599.197 | 5,86 % |
General Public | 4.451.113 | 43,5 % |
Individual Insiders | 4.630.460 | 45,3 % |
Verwässerung von Anteilen: ELTX erst kürzlich innerhalb der letzten 12 Monate aufgeführt.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2.595.072 | US$23.0m | 0 % | no data | |||
1.915.639 | US$17.0m | 0 % | no data | |||
599.197 | US$5.3m | -4,04 % | 48,26 % | |||
199.564 | US$1.8m | 0 % | no data | |||
174.894 | US$1.5m | 24,5 % | no data | |||
119.749 | US$1.1m | 0 % | no data | |||
50.000 | US$442.5k | -23,1 % | 0,34 % | |||
44.344 | US$392.4k | 59,1 % | no data | |||
16.466 | US$145.7k | 0 % | no data | |||
14.005 | US$123.9k | -13,6 % | no data | |||
13.899 | US$123.0k | 0 % | no data | |||
12.500 | US$110.6k | 0 % | no data | |||
5.414 | US$47.9k | -9,98 % | no data | |||
2.363 | US$20.9k | 0 % | no data | |||
2.045 | US$18.1k | 5.280 % | no data | |||
1.554 | US$13.7k | 0 % | no data | |||
1.146 | US$10.1k | 0 % | no data | |||
917 | US$8.1k | 0 % | no data | |||
374 | US$3.3k | 0 % | no data | |||
350 | US$3.1k | 0 % | no data | |||
157 | US$1.4k | 0 % | no data | |||
100 | US$886.5 | -71,4 % | no data | |||
78 | US$687.5 | 36,8 % | no data | |||
43 | US$379.9 | 95,5 % | no data | |||
16 | US$144.7 | 0 % | no data |